AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2

The drug repurposing of known approved drugs (e.g., lopinavir/ritonavir) has failed to treat SARS-CoV-2-infected patients. Therefore, it is important to generate new chemical entities against this virus. As a critical enzyme in the lifecycle of the coronavirus, the 3C-like main protease (3CLpro or M...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bowen, He, Fengming, Liu, Dongpeng, He, Fei, Wu, Tong, Fang, Meijuan, Niu, Zhangming, Wu, Zhen, Xu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220321/
https://www.ncbi.nlm.nih.gov/pubmed/35740872
http://dx.doi.org/10.3390/biom12060746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220321/
https://www.ncbi.nlm.nih.gov/pubmed/35740872
http://dx.doi.org/10.3390/biom12060746

Ejemplares similares